tiprankstipranks
Promising Outlook for Longeveron: ELPIS II Trial Progress and Financial Strength Highlighted
PremiumRatingsPromising Outlook for Longeveron: ELPIS II Trial Progress and Financial Strength Highlighted
9d ago
Longeveron Inc. Reports Strong 2024 Financial Growth
Premium
Company Announcements
Longeveron Inc. Reports Strong 2024 Financial Growth
12d ago
Longeveron reports Q4 revenue $700,000, consensus $637,500
Premium
The Fly
Longeveron reports Q4 revenue $700,000, consensus $637,500
12d ago
Longeveron initiated with a Buy at Roth MKM
PremiumThe FlyLongeveron initiated with a Buy at Roth MKM
3M ago
Longeveron initiated with a Buy at Roth MKM
Premium
The Fly
Longeveron initiated with a Buy at Roth MKM
3M ago
Longeveron reports Q3 EPS (34c), consensus (44c)
Premium
The Fly
Longeveron reports Q3 EPS (34c), consensus (44c)
4M ago
Longeveron price target lowered to $6 from $15 at Maxim
PremiumThe FlyLongeveron price target lowered to $6 from $15 at Maxim
7M ago
Longeveron reports Q2 EPS ($1.83), consensus (87c)
Premium
The Fly
Longeveron reports Q2 EPS ($1.83), consensus (87c)
7M ago
LGVN Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
LGVN Earnings this Week: How Will it Perform?
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100